[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SG11201600334SA - Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof - Google Patents

Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof

Info

Publication number
SG11201600334SA
SG11201600334SA SG11201600334SA SG11201600334SA SG11201600334SA SG 11201600334S A SG11201600334S A SG 11201600334SA SG 11201600334S A SG11201600334S A SG 11201600334SA SG 11201600334S A SG11201600334S A SG 11201600334SA SG 11201600334S A SG11201600334S A SG 11201600334SA
Authority
SG
Singapore
Prior art keywords
fhbp
methods
naturally occurring
binding proteins
occurring factor
Prior art date
Application number
SG11201600334SA
Other languages
English (en)
Inventor
Peter T Beernink
Original Assignee
Children S Hospital & Res Ct Oakland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Children S Hospital & Res Ct Oakland filed Critical Children S Hospital & Res Ct Oakland
Publication of SG11201600334SA publication Critical patent/SG11201600334SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201600334SA 2013-08-02 2014-08-01 Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof SG11201600334SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361861662P 2013-08-02 2013-08-02
PCT/US2014/049465 WO2015017817A1 (en) 2013-08-02 2014-08-01 Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof

Publications (1)

Publication Number Publication Date
SG11201600334SA true SG11201600334SA (en) 2016-02-26

Family

ID=52432473

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201600334SA SG11201600334SA (en) 2013-08-02 2014-08-01 Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof

Country Status (13)

Country Link
US (1) US9914756B2 (ru)
EP (1) EP3027206A4 (ru)
JP (1) JP2016527278A (ru)
KR (1) KR20160034401A (ru)
CN (1) CN105431167A (ru)
AU (1) AU2014296027A1 (ru)
BR (1) BR112016002150A2 (ru)
CA (1) CA2918547A1 (ru)
EA (1) EA201690056A8 (ru)
IL (1) IL243535A0 (ru)
MX (1) MX2016001412A (ru)
SG (1) SG11201600334SA (ru)
WO (1) WO2015017817A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015292615B2 (en) 2014-07-23 2019-10-24 Children's Hospital & Research Center At Oakland Factor H binding protein variants and methods of use thereof
EP3298031B1 (en) * 2015-05-18 2020-10-21 BiOMVis Srl Immunogenic compositions containing bacterial outer membrane vesicles and therapeutic uses thereof
KR101865757B1 (ko) 2017-12-06 2018-06-08 김기성 저영향개발형 수처리장치
MX2023009728A (es) 2021-02-19 2023-08-30 Sanofi Pasteur Inc Vacuna recombinante meningococica b.
TW202423477A (zh) 2022-08-03 2024-06-16 美商賽諾菲巴斯德公司 針對腦膜炎奈瑟氏菌b的含佐劑免疫原性組成物
WO2024095289A1 (en) * 2022-11-04 2024-05-10 Techinvention Lifecare Private Limited Mutated factor H binding proteins (fHbp) of Neisseria meningitidis, their compositions and use thereof.

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1210305C (zh) 1998-05-01 2005-07-13 希龙公司 脑膜炎奈瑟球菌抗原和组合物
US20070026021A1 (en) 1998-05-01 2007-02-01 Chiron S.R.I. Neisseria meningitidis antigens and compositions
AU2013206190A1 (en) * 1999-11-29 2013-06-27 Novartis Vaccines And Diagnostics S.R.L. Compositions comprising Neisseria meningitidis antigens from serogroups B and C as well as a further antigen
PT1897555E (pt) 2000-01-17 2014-10-10 Novartis Vaccines & Diagnostic Vacina omv suplementada contra meningococos
GB0121591D0 (en) * 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
US7785608B2 (en) 2002-08-30 2010-08-31 Wyeth Holdings Corporation Immunogenic compositions for the prevention and treatment of meningococcal disease
JP4697706B2 (ja) 2002-10-11 2011-06-08 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル 高毒性髄膜炎菌系統に対する広範な防御のためのポリペプチド−ワクチン
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741
JP5173194B2 (ja) 2003-12-23 2013-03-27 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB0419408D0 (en) 2004-09-01 2004-10-06 Chiron Srl 741 chimeric polypeptides
BRPI0607374B8 (pt) * 2005-01-27 2021-05-25 Childrens Hospital & Res Center At Oakland vacinas de vesículas baseadas em gna1870 para proteção de amplo espectro contra doenças causadas por neisseria meningitidis
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
CA2695467A1 (en) 2007-08-02 2009-03-26 Children's Hospital & Research Center At Oakland Fhbp- and lpxl1-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
EP3263591B1 (en) 2008-02-21 2019-03-27 GlaxoSmithKline Biologicals S.A. Meningococcal fhbp polypeptides
EP2265640B1 (en) 2008-03-10 2015-11-04 Children's Hospital & Research Center at Oakland Chimeric factor h binding proteins (fhbp) containing a heterologous b domain and methods of use
EP2326726A4 (en) 2008-08-27 2011-09-28 Childrens Hosp & Res Ct Oak FACTOR-BASED H-FACTOR ASSAYS TO DETERMINE BACTERICIDE SERIAL ACTIVITY AGAINST NEISSERIA MENINGITIDIS
WO2010028096A2 (en) 2008-09-03 2010-03-11 Children's Hospital & Research Center At Oakland Peptides presenting an epitope of an a domain of factor h binding protein and methods of use
IT1394288B1 (it) * 2008-09-12 2012-06-06 Novartis Vaccines & Diagnostic Immunogeni di proteine che legano il fattore h.
GB0819633D0 (en) 2008-10-25 2008-12-03 Isis Innovation Composition
LT2411048T (lt) * 2009-03-24 2020-06-25 Glaxosmithkline Biologicals Sa Adjuvantinį meningokokinį faktorių h surišantis baltymas
WO2010127172A2 (en) 2009-04-30 2010-11-04 Children's Hospital & Research Center At Oakland Chimeric factor h binding proteins (fhbp) and methods of use
US20130022633A1 (en) 2009-10-27 2013-01-24 University Of Florence MENINGOCOCCAL fHBP POLYPEPTIDES
TR201802933T4 (tr) 2010-03-30 2018-03-21 Childrens Hospital & Res Center At Oakland Özellikleri değiştirilmiş faktör h bağlama proteinleri (fhbp) ve bunların kullanım yöntemi.
EP2729167B1 (en) 2011-07-07 2018-03-14 De Staat der Nederlanden, vert. door de Minister van VWS A process for detergent-free production of outer membrane vesicles of a gram-negative bacterium
WO2013078223A1 (en) 2011-11-23 2013-05-30 Children's Hospital & Research Center Oakland Anti-factor h binding protein antibodies and methods of use thereof

Also Published As

Publication number Publication date
EP3027206A4 (en) 2017-03-08
US9914756B2 (en) 2018-03-13
AU2014296027A1 (en) 2016-02-04
IL243535A0 (en) 2016-03-31
CN105431167A (zh) 2016-03-23
CA2918547A1 (en) 2015-02-05
EA201690056A8 (ru) 2017-07-31
WO2015017817A1 (en) 2015-02-05
BR112016002150A2 (pt) 2017-09-12
EA201690056A1 (ru) 2016-07-29
MX2016001412A (es) 2016-10-28
EP3027206A1 (en) 2016-06-08
US20160159865A1 (en) 2016-06-09
KR20160034401A (ko) 2016-03-29
JP2016527278A (ja) 2016-09-08

Similar Documents

Publication Publication Date Title
IL280155A (en) Anti- SIGLEC-8 antibodies and methods of using them
IL290547A (en) Antibodies and methods of use
IL246921A0 (en) Binding proteins and their uses
ZA201603308B (en) Novel anti-claudin antibodies and methods of use
IL244495B (en) Anti-alpha-synuclein antibodies and methods of use
IL245946A0 (en) Anti-dpep3 antibodies and methods of use
EP3054973A4 (en) Tm4sf1 binding proteins and methods of using same
HK1225612A1 (zh) 抗ly6e抗體及使用方法
IL243535A0 (en) Unnatural factor h binding proteins and methods of using them
EP3172224A4 (en) Factor h binding protein variants and methods of use thereof
EP2975062A4 (en) PREPARATION AND USE OF DIMERIZED FUSION PROTEIN